Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: outcomes from an Expanded Access Program.
Vicente VillanuevaDaniel Santos-CarrascoPablo Cabezudo-GarcíaAsier Gómez-IbáñezMercedes GarcésPedro Jesús Serrano-CastroMaria D Castro-VilanovaDébora SayasFrancisco J Lopez-GonzalezXiana Rodríguez-OsorioGustavo Torres-GaonaRosa A Saiz-DiazKevin G HampelMeritxell Martinez-FerriMaria J Aguilar-AmatBlanca Mercedes-AlvarezVanessa García-MoralesAna Del Villar-IgeaAndreu Massot-TarrúsJuan J Rodríguez-UrangaPublished in: Epilepsia open (2023)
In this highly refractory population, CNB showed a high response regardless of prior and concomitant ASMs. AEs were frequent but mostly mild-to-moderate, and few led to discontinuation.